150 related articles for article (PubMed ID: 15669555)
1. Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression.
Rudolph I; Palombo-Kinne E; Kirsch B; Mellinger U; Breitbarth H; Gräser T
Climacteric; 2004 Sep; 7(3):301-11. PubMed ID: 15669555
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients.
Saletu B; Anderer P; Gruber D; Metka M; Huber J; Saletu-Zyhlarz GM
Maturitas; 2002 Nov; 43(3):165-81. PubMed ID: 12443834
[TBL] [Abstract][Full Text] [Related]
3. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone.
Saletu-Zyhlarz G; Anderer P; Gruber G; Mandl M; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Abu-Bakr MH; Grätzhofer E; Saletu B
J Sleep Res; 2003 Sep; 12(3):239-54. PubMed ID: 12941063
[TBL] [Abstract][Full Text] [Related]
4. Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia.
Anderer P; Semlitsch HV; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Gräser T; Oettel M
Psychoneuroendocrinology; 2003 Apr; 28(3):419-45. PubMed ID: 12573306
[TBL] [Abstract][Full Text] [Related]
5. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
Saletu B
Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Gräser T; Koytchev R; Müller A; Oettel M
Climacteric; 2000 Jun; 3(2):109-18. PubMed ID: 11910651
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
[TBL] [Abstract][Full Text] [Related]
8. Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.
Gräser T; Römer T; Wiedey KD; Janaud A
Climacteric; 2001 Dec; 4(4):332-42. PubMed ID: 11770190
[TBL] [Abstract][Full Text] [Related]
9. The role of antiandrogens in hormone replacement therapy.
Schneider HP
Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
Georgiev DB; Manassiev NA
Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
[TBL] [Abstract][Full Text] [Related]
11. The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
Pirimoglu ZM; Aygun E; Dansuk R; Kucukercan I; Unal O; Turan C
Gynecol Endocrinol; 2005 Sep; 21(3):185-8. PubMed ID: 16335913
[TBL] [Abstract][Full Text] [Related]
12. A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women.
Endrikat J; Lange E; Kunz M; Schmidt W; Graeser T
Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):229-39. PubMed ID: 17763261
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial.
Jensen JT; Parke S; Mellinger U; Machlitt A; Fraser IS
Obstet Gynecol; 2011 Apr; 117(4):777-787. PubMed ID: 21422847
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
Linzmayer L; Semlitsch HV; Saletu B; Böck G; Saletu-Zyhlarz G; Zoghlami A; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Grünberger J
Arzneimittelforschung; 2001; 51(3):238-45. PubMed ID: 11304940
[TBL] [Abstract][Full Text] [Related]
15. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
Mueck AO; Seeger H; Gräser T; Oettel M; Lippert TH
Horm Metab Res; 2001 Dec; 33(12):744-7. PubMed ID: 11753761
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
[TBL] [Abstract][Full Text] [Related]
17. [Acceptability of continuous combined versus cyclical HRT: a French multicentric randomized clinical study].
Drapier-Faure E; Azoulay C; Abramovici Y
Gynecol Obstet Fertil; 2005; 33(7-8):498-504. PubMed ID: 16005674
[TBL] [Abstract][Full Text] [Related]
18. Estradiol valerate/dienogest.
Wellington K; Perry CM
Drugs; 2002; 62(3):491-504; discussion 505-6. PubMed ID: 11827562
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
von Schoultz B
Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841
[TBL] [Abstract][Full Text] [Related]
20. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.
Conner P; Söderqvist G; Skoog L; Gräser T; Walter F; Tani E; Carlström K; von Schoultz B
Breast Cancer Res Treat; 2003 Mar; 78(2):159-65. PubMed ID: 12725416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
